BELITE BIO INC - ADR (BLTE) Stock Income Statement
NASDAQ:BLTE • US07782B1044
167.88 USD
-9.7 (-5.46%)
At close: Mar 3, 2026
167.88 USD
0 (0%)
After Hours: 3/3/2026, 8:00:02 PM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 53.85M | 40.00M | 31.67M | 12.82M | 9.80M | |||
| Research and Development | N/A | 29.94M | 24.84M | 8.87M | 7.42M | |||
| Selling, General, and Administrative Expenses | 19.77M | 10.06M | 6.82M | 3.95M | 2.38M | |||
| Operating Income | -53.85M | -40.00M | -31.67M | -12.82M | -9.80M | |||
| Interest Income/Expense | N/A | 3.86M | 45.00K | 170.00K | 130.00K | |||
| Other Income/Expense | 4.94M | 4.00M | N/A | N/A | N/A | |||
| Income Before Taxes | -49.28M | -36.14M | -31.62M | -12.65M | -9.67M | |||
| Income Tax | 0.00 | 6.00K | 9.00K | 0.00 | 0.00 | |||
| Net Income | -49.28M | -36.14M | -31.63M | -12.65M | -9.67M | |||
| EBITDA | N/A | -39.83M | -31.53M | -12.76M | -9.77M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.27 | -0.97 | -0.97 | -0.52 | -0.33 | |||
| Non GAAP EPS | -1.92 | -1.18 | -1.24 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD